Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

New crystal form of vecuronium bromide, and preparation method and use thereof

A technology of vecuronium bromide and crystal form, which can be applied to medical preparations, pharmaceutical formulations, steroids and other directions containing active ingredients, can solve the problems of long production cycle, high cost, increase clinical risks and hidden dangers, etc. The effect of stimulating blood vessels, simple preparation process and improving solubility

Active Publication Date: 2013-12-18
SICHUAN CREDIT CHEMWERTH PHARMACEUTICAL CO LTD
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Among them, the former is a freeze-dried powder injection, which has disadvantages such as long production cycle, high cost, and unfavorable product cost savings; at the same time, the auxiliary amino acid added in the preparation is unstable, which will accelerate the instability of the drug and increase the preparation cost. (see CN102319215A)
And the latter used additives such as a large amount of cholesterol, phosphatidylethanolamine, soybean lecithin, Tween 80, PVP in the preparation process of liposome injection, and this influenced the curative effect of vecuronium bromide to a certain extent, increased Necessary clinical risks and hidden dangers, and the proportion of each component added in the preparation process must be strictly controlled, otherwise the quality and curative effect of the injection will be greatly reduced
There is no relevant report on the crystal form of vecuronium bromide

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • New crystal form of vecuronium bromide, and preparation method and use thereof
  • New crystal form of vecuronium bromide, and preparation method and use thereof
  • New crystal form of vecuronium bromide, and preparation method and use thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0053] The preparation of embodiment 1 vecuronium bromide crystal form II

[0054] Put vecuronium bromide in an alcohol and ether solution (see Table 1 for the relevant proportions of the two solvents and related preparation conditions), heat and stir to dissolve properly, add a certain amount of activated carbon, and filter; the mother liquor is left standing / stirred to precipitate crystals; filter and collect Crystals were dried under reduced pressure to obtain Type II crystals of vecuronium bromide with a yield of 99%.

[0055] In the present invention, the added amount of activated carbon is preferably 1wt.%-5wt.% of the weight of vecuronium bromide.

[0056] Table 1 Solvent ratio and related preparation conditions of vecuronium bromide crystal form Ⅱ

[0057]

[0058] According to the detection method described in Example 1, the crystal prepared by No. 2 in Table 1 was measured (see Table 5 for melting point related data), and determined by powder X-ray diffraction to...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
melting pointaaaaaaaaaa
Login to View More

Abstract

The invention discloses a new crystal form II of vecuronium bromide. There are characteristic peaks at 2theta diffraction angles of 8.3+ / -0.2DEG, 11.7+ / -0.2DEG, 14.1+ / -0.2DEG, 15.7+ / -0.2DEG, 18.0+ / -0.2DEG and 21.3+ / -0.2DEG in the X-ray powder diffraction pattern of the crystal form. The invention also discloses a preparation method of the crystal form and a use of the crystal form. The crystal form II of vecuronium bromide improves the dissolvability of vecuronium bromide, is helpful for mitigating or eliminating the untoward effects of blood vessel irritation and ache initiation during injection, reduces the hydroscopic property of vecuronium bromide, substantially enhances the stability of vecuronium bromide, is in favor of the long term storage of a vecuronium bromide raw material and guarantees the product safety through the change of the crystal form structure. The preparation method of the crystal form II of vecuronium bromide has the advantages of simplicity, convenient operation and high yield, and is benefit for the large scale production of the crystal form II of vecuronium bromide.

Description

technical field [0001] The invention relates to a new crystal form of vecuronium bromide, a preparation method and application of the crystal form. Background technique [0002] Vecuronium bromide (structure shown in formula 1) was first listed in the Netherlands in 1982, and is widely used in clinical practice mainly as an adjuvant to general anesthesia. It belongs to the medium and short-acting non-depolarizing muscle relaxants of monoquaternary ammonium sterols, which can compete with acetylcholine for the nicotinic receptors located on the motor endplate of striated muscles and block the signal transduction between nerve endings and striated muscles. Endotracheal intubation during general anesthesia and muscle relaxation during surgery. Vecuronium bromide will not release histamine after entering the human body, and can effectively reduce possible adverse reactions such as vomiting, aspiration and even hypoxia during intubation. Compared with the existing muscle relaxa...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07J43/00A61K31/58A61P21/02
Inventor 傅霖李文婕陈刚
Owner SICHUAN CREDIT CHEMWERTH PHARMACEUTICAL CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products